Human Genome Sciences Inc. (HGSI)
Trading Center
Loading...
Symbols:
HGSI Forum Topics
loading ...Recent HGSI Articles
- Bioterrorism: Anthrax and Biotech Companies
- Biotech Stocks' Various Lupus Therapies: Opportunity or Lost Cause?
- Insider Buying in Biotech Land
- Hepatitis C Developments Drag Biotechs Down
- PowerHouse Week for Economic Calendar
- Biotech Day in Review: Xoma Signs $230 Million Partnership with Takeda
- Glaxo and HGS's Announcement: Reading Between the Lines
- Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis
- Biotech Stocks Day-in-Review: Amgen Strikes Drug Deal With Cytokinetics
- IPO Analysis: Perlegen and Genetically Targeted Medications (PERL)
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Bioterrorism: Anthrax and Biotech Companies [view article]
"Groups not aligned with countries have used anthrax. Most dramatically, in October 2001, anthrax attacks were perpetrated in the U.S. via the mail, when seven envelopes containing B. anthracis spores were sent through the U.S. postal system. Twenty-two cases of anthrax resulted (11 inhalational, 11 cutaneous), and 5 people died from inhalational anthrax. Investigations into the origin of the attacks are ongoing, and the perpetrator(s) have yet to be identified (source)."Since our current government is esentially a political branch of the GOP...
If the GOP was the source of anthrax (you forgot to note that ALL of the political victims of the anthrax mailings were DEMOCRATS)...
Why on earth would the GOP investigate itself and turn itself in?
Reply
Bioterrorism: Anthrax and Biotech Companies [view article]
ADLS is the way to go as the investment idea from the group. A partnership with a big pharma company will be announced before the end of September this year, to market and file the NDA for the antibiotic Cethro.... ReplyBiotech Stocks' Various Lupus Therapies: Opportunity or Lost Cause? [view article]
It is so sad that there are so few drugs to treat Lupus, and there is no cure. My daughter-in-law has Lupus and would absolutely love to have a baby, but without treatment her Lupus acts up. She was diagnosed in college when she had a major "flare", and even though she is a healthcare professional, she cannot find an adequate treatment. ReplyEditors
General Discussion on HGSI
Is this a buy or a sell? ReplyInsider Buying in Biotech Land [view article]
you watch insider buying, so do I, but they are notoriously early....Suggest you look at SCLN. Reply